Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michael A Veronin. (2022) An Atypical Case of Extreme Polypharmacy. Drug, Healthcare and Patient Safety 14, pages 19-26.
Read now
Read now
Articles from other publishers (19)
Ursina Wernli, Désirée Hischier, Christoph R. Meier, Sibylle Jean-Petit-Matile, Alice Panchaud, Andrea Kobleder & Carla Meyer-Massetti. (2022) Prescription Trends in Hospice Care: A Longitudinal Retrospective and Descriptive Medication Analysis. American Journal of Hospice and Palliative Medicine® 40:8, pages 820-828.
Crossref
Crossref
Komal Patel Murali, John D. Merriman, Gary Yu, Allison Vorderstrasse, Amy S. Kelley & Abraham A. Brody. (2023) Complex Care Needs at the End of Life for Seriously Ill Adults With Multiple Chronic Conditions. Journal of Hospice & Palliative Nursing 25:3, pages 146-155.
Crossref
Crossref
Sofie Rosenlund Lau, Frans Waldorff, Anne Holm, Anne Frølich, John Sahl Andersen, Mette Sallerup, Sarah Emilie Christensen, Stine Søndersted Clausen, Tina Drud Due & Pernille Hølmkjær. (2023) Disentangling concepts of inappropriate polypharmacy in old age: a scoping review. BMC Public Health 23:1.
Crossref
Crossref
Najwa Taghy, Viviane Ramel, Ana Rivadeneyra, Florence Carrouel, Linda Cambon & Claude Dussart. (2023) Exploring the Determinants of Polypharmacy Prescribing and Dispensing Behaviors in Primary Care for the Elderly—Qualitative Study. International Journal of Environmental Research and Public Health 20:2, pages 1389.
Crossref
Crossref
Ashleigh Gorman, Audrey Rankin, Carmel Hughes, Máire O'Dwyer & Cristín Ryan. (2022) Theoretically derived interventions aimed at improving appropriate polypharmacy in primary care: A systematic review. Exploratory Research in Clinical and Social Pharmacy 7, pages 100166.
Crossref
Crossref
Temesgen Sidamo, Alemu Deboch, Mohamed Abdi, Fikru Debebe, Khalid Dayib & Tamrat Balcha Balla. (2022) Assessment of Polypharmacy, Drug Use Patterns, and Associated Factors at the Edna Adan University Hospital, Hargeisa, Somaliland. Journal of Tropical Medicine 2022, pages 1-8.
Crossref
Crossref
Ghada Bawazeer, Saad Alsaad, Haya Almalag, Alhanouf Alqahtani, Noura Altulaihi, Abdulaziz Alodhayani, Abdulaziz AlHossan & Ibrahim Sales. (2022) Impact of Specialized Clinics on Medications Deprescribing in Older Adults: A Pilot Study in Ambulatory Care Clinics in a Teaching Hospital. Saudi Pharmaceutical Journal 30:7, pages 1027-1035.
Crossref
Crossref
M.V. Khaitovych, V. A. Sova, K. Yu. Kyrylchuk, І.М. Sytnyk, V.O. Polovynka, О.А. Теmіrоvа & D.V. Turchak. (2022) PROBLEMATIC POLYPHARMACY IN OUTPATIENT THERAPY OF CHILDREN: POTENTIAL RISKS OF DRUG INTERACTIONS. Medical Science of Ukraine (MSU) 18:1, pages 35-39.
Crossref
Crossref
Francisco Mesonero, Cristina Fernández, Eugenia Sánchez-Rodríguez, Ana García-García Paredes, Carla Senosiain, Agustín Albillos & Antonio López-Sanromán. (2022) Polypharmacy in Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 56:3, pages e189-e195.
Crossref
Crossref
Balamurugan Tangiisuran, Vijitha Rajendran, Abubakar Sha’aban, Nur Aizati Athirah Daud & Siti Nurbaya Mohd Nawi. (2021) Physicians’ perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study. International Journal of Clinical Pharmacy 44:1, pages 201-213.
Crossref
Crossref
M.V. Khaitovych. (2022) Поліфармація: визначення, ризики, менеджмент. Oral and General Health 2:3, pages 7-12.
Crossref
Crossref
Jozef Kolář, Tünde Ambrus, Dominik Grega & Lenka Smejkalová. (2022) Příspěvek k pojmu polypragmazie I. Etymologické poznámky a charakteristika. Česká a slovenská farmacie 71:6, pages 245-250.
Crossref
Crossref
Penny Lun, Felicia Law, Esther Ho, Keng Teng Tan, Wendy Ang, Yasmin Munro & Yew Yoong Ding. (2021) Optimising prescribing practices in older adults with multimorbidity: a scoping review of guidelines. BMJ Open 11:12, pages e049072.
Crossref
Crossref
Niklas Frahm, Michael Hecker & Uwe Klaus Zettl. (2021) Polypharmacy in Chronic Neurological Diseases: Multiple Sclerosis, Dementia and Parkinson’s Disease. Current Pharmaceutical Design 27:38, pages 4008-4016.
Crossref
Crossref
Najwa Taghy, Linda Cambon, Caroline Boulliat, Olivier Aromatario & Claude Dussart. (2021) Exploring the Determinants of Polypharmacy Prescribing and Dispensing Behaviours in Primary Care for the Elderly—Protocol for a Qualitative Study. International Journal of Environmental Research and Public Health 18:14, pages 7656.
Crossref
Crossref
Farhad Pazan & Martin Wehling. (2021) Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. European Geriatric Medicine 12:3, pages 443-452.
Crossref
Crossref
Nicole J. Brandt & Hedva Barenholtz Levy. 2021. Geriatrics for Specialists. Geriatrics for Specialists
41
50
.
P. Ballester, A.L. Richdale, E.K. Baker & A.M. Peiró. (2020) Sleep in autism: A biomolecular approach to aetiology and treatment. Sleep Medicine Reviews 54, pages 101357.
Crossref
Crossref
Yasin I. Tayem, Marwa H. Al-Ghadani, Haitham A. Jahrami & Mazen K. Ali. (2019) Non-psychotropic Drug Interactions among Psychiatric Patients in Bahrain. Arab Gulf Journal of Scientific Research, pages 54-64.
Crossref
Crossref